SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-07-001071
Filing Date
2007-01-10
Accepted
2007-01-10 17:14:41
Documents
2
Period of Report
2007-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2248
2 EXHIBIT 24 - POWER OF ATTORNEY greene.txt EX-24.TXT 3374
  Complete submission text file 0001179110-07-001071.txt   7284
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Issuer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 617-252-0700
Greene Barry E (Reporting) CIK: 0001291963 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50513 | Film No.: 07523908